CITED2 Antikörper (Internal Region)

Produktnummer ABIN185552

Produktdetails anti-CITED2 Antikörper

Target: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Bindungsspezifität: Internal Region

Reaktivität: Human, Maus, Ratte, Rind (Kuh), Schwein, Hund

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser CITED2 Antikörper ist unkonjugiert

Applikation: ELISA

Verwendungszweck: CITED2 (Internal)

Sequenz: PNVIDTDFID EE

Homologie: Human, Mouse, Rat, Dog, Pig, Cow

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Recent

Immunogen: Peptide with sequence C-PNVIDTDFIDEE, from the internal region of the protein sequence according to NP_006070.2.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

DS WB Results: Preliminary experiments in adult human heart, kidney, liver and skin lysates gave no specific signal but low background (at antibody concentration up to 1 μg/mL).

Peptide ELISA: antibody detection limit dilution 1:4000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu CITED2

Target: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Andere Bezeichnung: CITED2 (CITED2 Produkte)

Synonyme: mrg1 antikoerper, p35srj antikoerper, zgc:103418 antikoerper, CITED2 antikoerper, cite2 antikoerper, ASD8 antikoerper, MRG-1 antikoerper, MRG1 antikoerper, P35SRJ antikoerper, VSD2 antikoerper, AI835299 antikoerper, ER154-like antikoerper, Mrg1 antikoerper, Msg2 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 antikoerper, Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 antikoerper, Cbp/p300-interacting transactivator 2 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 L homeolog antikoerper, cited2 antikoerper, CITED2 antikoerper, cite2 antikoerper, Cited2 antikoerper, cited2.L antikoerper

Hintergrund: CITED2, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 , HGNC:1987, MRG1, P35SRJ

Gen-ID: 10370

NCBI Accession: NP_006070

Pathways: Tube Formation